INTRODUCTION {#SEC1}
============

Most energy stored in nutrients is converted into ATP, aerobically, by the mitochondrial oxidative phosphorylation system (OXPHOS). The OXPHOS system consists of four enzymatic complexes that form the mitochondrial respiratory chain and a fifth complex, the F~o~F~1~ ATPase that drives the synthesis of ATP. The OXPHOS complexes comprise approximately 100 proteins of dual genetic origin. Some additional hundred nucleus-encoded proteins are required for their biogenesis ([@B1]). The complete mitochondrial proteome comprises approximately 800 (yeast) to 1500 (humans) proteins depending on the complexity of the eukaryotic organism ([@B2],[@B3]). The vast majority of these proteins are encoded in the nuclear genome, translated by cytoplasmic ribosomes and imported into mitochondria. Only a handful of proteins (8 in yeast and 13 in humans), all essential components of the OXPHOS complexes, are encoded by the mitochondrial genome, translated by mitochondrial ribosomes and assembled with the newly imported proteins to form the OXPHOS system ([@B4],[@B5]). Mitochondrial ribosomes and the translation process are closer to those of their bacterial ancestor than to their cytoplasmic counterparts, as demonstrated by the sensitivity to antibiotics and other properties, although two billion years of mitochondrial evolution resulted for example in deviations in the genetic code ([@B6],[@B7]) and significant differences in the actual process of translation ([@B8],[@B9]). Mitochondria have a simplified decoding system that allows a small set of mitochondrial tRNAs to recognize all the codons ([@B10],[@B11]). The 24 mitochondrial tRNAs of *S. cerevisiae* and the 22 human mitochondrial tRNAs are encoded by the mtDNA genome. However, in some species, tRNAs need to be imported from the cytosol. This requirement is extended to some tRNAs for yeast and human mitochondria under stress conditions such as elevated temperature ([@B12],[@B13]).

The study of the functional mitochondrial proteome has traditionally exploited the facultative aerobe/anaerobe growth capacity of the yeast *Saccharomyces cerevisiae*. This property allowed for the selection of respiratory deficient strains, which remain viable when grown in the presence of fermentable carbon sources such as glucose. Fifty years ago, chemical mutagenesis, followed by selection of respiratory mutants -so called mitochondrial or nuclear *petite* (*pet*) mutants- was probably the first successful high-throughput approach towards the characterization of the mitochondrial proteome (reviewed in ([@B14]--[@B16])). Because of the conservation of fundamental cellular processes and genes between yeast and humans ([@B17],[@B18]), *S. cerevisiae* is also an invaluable lower eukaryotic model system to identify and characterize human genes involved in mitochondrial diseases (reviewed in ([@B19]--[@B21]) and references therein). In fact, many human genes responsible for mitochondrial diseases were first identified in yeast ([@B19]). Over the last decade, a number of genome-wide approaches, including subcellular localization and *in silico* prediction studies ([@B22],[@B23]), and whole exome sequencing ([@B24]) have facilitated the identification of nuclear genes involved in mitochondrial function and disease. However, the availability of deletion mutant collections covering nearly all protein-coding genes in different genetic formats (haploid, homozygous diploid and heterozygous diploid; reviewed in ([@B25])) has offered a powerful means, thus far unique to yeast, to exploit *S. cerevisiae* as a model organism to pursue the characterization of not only the mitochondrial proteome but also the extended mitochondrial regulome. In particular, systematic screens of the haploid mutant collection searching for mutants able to grow on fermentable carbon sources (glucose) but not on non-fermentable, respiratory carbon sources (ethanol, glycerol or lactate), have led to the identification of novel genes involved in mitochondrion structure and function ([@B26]--[@B30]). Additionally, recent data indicate that hundreds of non-mitochondrial proteins involved in different (and seemingly disparate) cellular processes, can also play a role in optimizing or regulating OXPHOS function ([@B31]), thus contributing to the so called mitochondrial regulome. However, despite research efforts by a growing number of laboratories worldwide, the integration of mitochondrial function with other cellular processes and metabolic networks that can impair respiratory capacity and OXPHOS when mutated is thus still poorly understood and approximately one third of the 800 proteins thought to constitute the yeast mitochondrial proteome and of the 1500 proteins estimated to conform the mammalian mitochondrial proteome remain to be identified ([@B23],[@B32]).

In all studies conducted so far, the ability of mutant strains to grow on respiratory carbon sources was monitored at the optimal growth temperature of 30°C. However, deletion of some genes involved in functions as diverse as DNA/RNA interaction ([@B33]), OXPHOS complex assembly ([@B34]--[@B37]) and oxidative stress response ([@B38]) leads to a respiratory defect exclusively at high temperature (37°C). Therefore, we anticipated that a deletion mutant collection screening conducted under heat-stress conditions would have the potential to uncover new genes and pathways involved in regulation of mitochondrial biogenesis and function. As a result of this modified screening we discovered 105 previously unidentified genes (67% orthologous to human genes) whose deletion interferes with mitochondrial OXPHOS function. Notably, 10% of these genes are involved in wobble uridine modification of a specific subset of nuclear-encoded tRNAs.

MATERIALS AND METHODS {#SEC2}
=====================

Yeast strains and media {#SEC2-1}
-----------------------

The MATα deletion library (BY4742 background) was purchased from Open Biosystems (Huntsville, AL, USA) and converted into a 384-well plate format by manual multipinning ([@B39]). Strains were grown at 30°C or 37°C in YP (1% yeast extract, 2% peptone) complete standard media or synthetic complete (SC) media (0.19% YNB, 0.5% ammonium sulphate, 1 g/l dropout mix without uracil) as specified in the text; media were supplemented with various carbon sources (2%, w/v each) as indicated.

OXPHOS mutant screening {#SEC2-2}
-----------------------

A total of 4688 haploid deletion mutants were utilized for genomic phenotyping, which was performed as described ([@B39]). Individual plates from the deletion mutant collection (384-wells master plates with seven empty control-wells plus the BY4742 *rho^0^* strain in one well) were inoculated with 50 μl of G418 (200 μg/ml) containing liquid YPD medium using a 384 pin tool (VP 384F; V&P Scientific Inc., San Diego). After 2 days at 30°C, cells were transferred to YP-agar (without G418), supplemented with either glucose or ethanol as a carbon source and cultured for 2 days at 30 and 37°C, followed by plate examination for respiratory growth based on relative colony size and digital image recording. Four replicate screens, using independent starter cultures, were carried out for each condition, followed by verification of mutant strains that were scored as sensitive in at least two screens by serial dilution spot assays. These were performed by pre-growing selected candidate mutants at 30°C in YPD medium for 24 h, followed by determination of OD~600~ with a microplate reader, adjustment of cell density to an OD~600~ value of 1.0 with YPD medium and serial dilution in ten-fold increments. Aliquots (4 μl) of each dilution were then spotted onto YP-agar plates supplemented with glucose, ethanol, glycerol or lactate and growth was examined after incubation at 30°C and 37°C for 2--3 days. Mutant strains exhibiting a growth reduction on ethanol at the first, second and third or fourth dilution were classified as 'highly' (HS), 'medium' (MS) or 'lowly' (LS) sensitive, respectively (Supplementary Table S1).

To determine mitochondrial DNA mutation rate, 'petite' (*pet*) frequency, defined as the percentage of colonies displaying a petite phenotype after a 5-day incubation at 37°C, was evaluated as described previously ([@B40]); at least 4000 colonies were analyzed for each strain.

Gene ontology analysis was done using Funspec program (GO Biological Process; <http://funspec.med.utoronto.ca/>).

Cytochrome spectra and mitochondrial respiration analysis {#SEC2-3}
---------------------------------------------------------

Reduced vs. oxidized spectra were recorded (Varian Cary300 UV-VIS Spectrophotometer) at room temperature on suspensions of cells cultured for 24 h at 37°C in SC medium containing a non-repressing glucose concentration (0.6%, w/v). Oxygen consumption rates were measured at 37°C on the same suspensions using a Clark-type oxygen electrode (Oxygraph System Hansatech Instruments England) containing 1 ml of air-saturated respiration buffer (0.1 M phthalate--KOH, pH 5.0, 10 mM glucose). The reaction was started by adding 20 mg equivalents of wet-weight cells as described previously ([@B41]).

*In vivo* mitochondrial protein synthesis {#SEC2-4}
-----------------------------------------

Mitochondrial gene products were labeled in whole cells at 30 and 37°C for 10 min with ^35^S-methionine (7 mCi/mmol; GE Healthcare, Little Chalfont, Buckinghamshire, United Kingdom) in the presence of 0.2 mg/ml cycloheximide to inhibit cytoplasmic protein synthesis ([@B42]). Equivalent amounts of pulsed total cellular proteins were precipitated with trichloroacetic acid (25% w/v), fractionated by SDS-PAGE (17.5% polyacrylamide gel), transferred to a nitrocellulose membrane and exposed to a Kodak X-OMAT X-ray film. Autoradiographic images were digitalized and densitometry performed with the Quantity One software (Bio-Rad).

Gene overexpression studies {#SEC2-5}
---------------------------

The *Escherichia coli* XL1-Blue strain was used for plasmid propagation and DNA cloning experiments. The coding sequences of the tRNA genes of interest \[*tR(UCU)M1*, *tK(UUU)L*, *tK(UUU)D*, *tK(CUU)G1*, *tT(UGU)G1*, *tG(UCC)O*, *tQ(UUG)C*, *tQ(CUG)M*, retrieved from SGD; see the text for further details\] and the *ELP3* gene were amplified by PCR using genomic DNA from the BY4742 strain as template and the oligonucleotides described in Supplementary Table S2 as primers. Individual amplicons were cloned into the YEp352 vector (*URA3* auxotrophic marker) using *Sal*I-*Kpn*I \[for *tG(UCC)O*, *tK(CUU)G1*, *tQ(UUG)C*, *tR(UCU)M1*, *tT(UGU)G1* genes\], *Bam*HI-*Sac*I \[for *tK(UUU)L*, *tK(UUU)D* genes\] and KpnI--BamHI \[for *tQ(CUG)M* and *ELP3* genes\] restriction/insertion sites. *tE(UUC)* as well as independent replicates of the *tQ(UUG)* and *tK(UUU)* tRNA gene constructs and a triple combination of these three tRNA genes (*tKQE*) all cloned in the pRS425 plasmid (*LEU2* auxotrophic marker) ([@B43]) were kindly provided by Dr. Patrick Pedrioli.

Yeast genes with a high AAA codon usage (*SPT7*, *VPS3*, *HFM1*, *CCM1*, *BCK1*, *PET309*, *NAM2*, *DSS1*, *FZO1*, *BEM2*; see Supplementary Table S3) and the *ELP3* gene cloned in the pGB1805 expression vector under control of a *GAL1* promoter were purchased from Thermo Scientific (Yeast ORF Collection). After sequence verification, individual plasmids were used for yeast transformation ([@B39]). Galactose, in combination with ethanol, was used as an inducer and a respirable carbon source ([@B44]) in these experiments.

Statistical analysis {#SEC2-6}
--------------------

Data are expressed as mean ± standard deviation (SD) from at least three independent experiments. Statistical analysis was performed by one-way analysis of variance (ANOVA) followed by Dunnett\'s post hoc test (GraphPad Prism 5 Software; \*\*, *P*-value ≤ 0.01; \*\*\*, *P*-value ≤ 0.001).

RESULTS {#SEC3}
=======

Genomic phenotyping analysis of mitochondrial function under thermal stress conditions {#SEC3-1}
--------------------------------------------------------------------------------------

We screened the yeast deletion mutant collection (4688 non-essential gene deletion strains in a haploid background) by growing the strains on rich solid medium containing either glucose (YPD), a fermentable carbon source, or ethanol (YPE), a non-fermentable (respiratory) carbon source, at 30°C and at 37°C, followed by fitness scoring and subsequent validation and characterization of the mutants exhibiting a growth defect in YPE.

The primary screening was performed in four replicates and *pet* mutants in at least two screens were individually verified by serial dilution assays conducted on YPD and YPE as explained in the 'Methods' section. We identified a total of 489 mutant strains displaying various degrees of growth impairment when cultured on YPE at 37°C (and/or at 30°C; see Table [1](#tbl1){ref-type="table"} for a summary of the results). The mutants were classified as high (HS), medium (MS) and low (LS) sensitive based on their serial dilution assay respiratory growth phenotypes (Figure [1A](#F1){ref-type="fig"}, but see also Table [1](#tbl1){ref-type="table"} and Supplementary Table S1). One hundred and thirty four mutant strains displayed an attenuated growth on YPE only at 37°C, while 355 mutants exhibited a respiratory defect also at 30°C. Two-hundred sixty-eight of the latter mutants failed to grow on YPE at both 30°C and 37°C, while a phenotype worsening effect at 37°C was observed for the remaining 87 mutants (Table [1](#tbl1){ref-type="table"}).

![Heat stress-dependent OXPHOS mutants. (**A**) Representative examples of *pet* mutant identification by genomic phenotyping (*left*) and corresponding serial dilution assays (*right*) used for mutant classification based on OXPHOS phenotype severity (HS, MS and LS: high-, medium- and low -sensitive mutants). A mitochondrial DNA-depleted *rho°* strain (ρ°) and the wild type (WT) strain were used as positive and negative controls, respectively; the names of the specific gene deletions utilized as representative examples are indicated on the right. Cytochrome spectra (**B**) and respiratory rates (**C**) used for further mutant classification (A, B, C, D in a decreasing order of severity).](gkv765fig1){#F1}

###### Classification of the 489 mutant strains displaying different degrees of respiratory growth impairment on YPE at 37°C and/or at 30°C

  Total number and type of mutants                                   HS^a^   MS^a^   LS^a^   New mutants   Human orthologs^b^
  ------------------------------------------------------------------ ------- ------- ------- ------------- --------------------
  134 mutants respiratory growth-defective only at 37°C              58      52      24      65            52 (80%)
  355 mutants respiratory growth-defective also at 30°C:                                                   
  --268 mutants respiratory growth-defective at both 30°C and 37°C   221     26      21      22            16 (73%)
  --87 mutants displaying a phenotype worsening effect at 37°C^c^    56^c^   31^c^   ---     18            8 (44%)

^a^Mutants were classified as high (HS), medium (MS) and low (LS) sensitive based on their serial dilution assay OXPHOS phenotypes (see also Figure [1A](#F1){ref-type="fig"} and Supplementary Table S1).

^b^The numbers (and percentages) of yeast genes with an orthologous counterpart in the human genome, only refers to the newly identified 105 genes that cause a respiratory growth defect when mutated.

^c^Number of mutants displaying a HS or MS OXPHOS phenotype at 37°C compared to a less severe phenotype at 30°C.

Comparison of our results with the *Saccharomyces Genome Database* (SGD, ([@B45])) and with the results of previous mitochondrion-targeted genomic phenotyping studies conducted at 30°C ([@B26]--[@B30]) showed that 77% (376 out of 489) of the genes retrieved by our screen encode previously characterized mitochondrial proteins (Supplementary Table S1). The remaining 113 genes, which have never been associated to mitochondrial function before, encode mostly non-mitochondrial proteins that could be potentially involved in regulation of mitochondrial processes (referred to as 'new' in Table [1](#tbl1){ref-type="table"} and in Supplementary Table S1).

To distinguish between a genuine OXPHOS impairment and other possible defects related to ethanol utilization or tolerance, these 113 mutant strains were individually verified by serial dilution assays carried out on rich medium supplemented with lactate, acetate or glycerol as carbon source. One hundred and five strains were found to display a defective growth on at least two different respiratory carbon sources, thus strongly suggesting an OXPHOS impairment. The remaining eight strains that exhibited a defective growth exclusively on ethanol-supplemented media (see Supplementary Table S4) had mutations in genes related to phospholipid biosynthesis, cell wall integrity and stress/heat resistance that probably affect ethanol tolerance, and were thus excluded from further analysis. Out of the 105 new mutants with a specific OXPHOS impairment, 65 had a respiratory growth-defective phenotype only at 37°C, 18 exhibited a phenotype worsening at this temperature, while the remaining 22 mutants were growth-defective even at 30°C (Table [1](#tbl1){ref-type="table"} and Supplementary Table S5). Most newly identified genes (95%) code for proteins of known function but not previously associated to mitochondrial biogenesis. Two gene products (Ldb16 and Ynl320w) were previously localized to the mitochondrion ([@B46]) but not characterized from a functional point of view, while four mutants are deleted in genes coding for as yet uncharacterized open reading frames. Seventy of the 105 newly identified genes that cause OXPHOS impairment when deleted have orthologous counterparts in the human genome (Table [1](#tbl1){ref-type="table"} and Supplementary Table S1).

Cytochrome spectra and respiration capacity of the newly identified mitochondrial mutants {#SEC3-2}
-----------------------------------------------------------------------------------------

To gain insight into the specific functional defects of the 105 new mutants identified by our screen, we determined the cytochrome absorption spectra and oxygen consumption rates for each mutant, using the isogenic wild type strain as a reference (see Supplementary Table S5 for the entire list of mutants and associated phenotypes). We also included a subset of 19 mutants previously identified as LS at 30°C, but not fully characterized in other screens ([@B26]) (Supplementary Table S6). These analyses highlighted a good correlation between cytochrome spectra and respiratory rates and allowed us to classify the mutant strains into four different classes (A--D) of decreasing phenotype severity (see Figure [1B](#F1){ref-type="fig"} and [C](#F1){ref-type="fig"}). Class A mutants are characterized by strongly altered cytochrome spectra and highly attenuated oxygen consumption rates; intermediate, but progressively less altered phenotypes are displayed by class B and C mutants, whereas class D mutants differ only slightly from the wild type strain. Mutant classes A-C are the most populated (85% of the entire mutant set; Figure [1C](#F1){ref-type="fig"}) thus indicating an important direct or indirect role of the corresponding gene products in the function of the OXPHOS system.

The set of newly identified genes is enriched in 'tRNA wobble uridine modification' components {#SEC3-3}
----------------------------------------------------------------------------------------------

As revealed by Gene Ontology (GO) 'biological process' analysis (Table [2](#tbl2){ref-type="table"}), the most significant and enriched GO categories matched by the newly identified heat-sensitive *pet* mutant strains were 'tRNA wobble uridine modification' (*P-*value = 2.1E−10) and 'protein urmylation' (*P-*value = 3.8E−06). The latter is a post-translational modification relying on the ubiquitin-like polypeptide Urm1 that acts on protein substrates ([@B47]) but also plays a crucial role in wobble uridine modification of some tRNAs via the thiolating enzyme complex Ncs6--Ncs2 ([@B48]--[@B50]). Multiple genes coding for proteins covering all steps of tRNA wobble uridine (U~34~) modification, specifically 5-methoxycarbonylmethyl-2-thiouridine (mcm^5^s^2^U~34~) formation that in yeast requires Elongator (ELP) and urmylation (Urm) pathway components plus the tRNA methyltransferase Trm9, are present in our mutant set (see Figure [2A](#F2){ref-type="fig"} for a schematic representation of the wobble uridine modification pathway). Additional components of this pathway that were also retrieved among the genes causing respiratory deficiency when deleted, include: Sit4 and Kti12, two proteins that positively influence ELP complex activity ([@B51],[@B52]); Urm1, previously identified as mitochondrial function-related ([@B28]) and Uba4, both needed for uridine thiolation ([@B48],[@B49]). Therefore, the main missing components are Elp5 and Trm112, plus Kti11 and Kti14, which are not present in the mutant collection, and Kti13 which was not found likely due to its relatively modest effect on mcm^5^s^2^ modification ([@B53]).

![Outline of respiration-deficient, wobble uridine modification pathway-related mutants and mitochondrial protein synthesis analysis of the *elp3Δ* and *ncs6Δ* mutant strains. (**A**) Schematic representation of the mcm^5^s^2^ uridine modification pathway and associated genes involved in this modification that cause respiratory deficiency when deleted. Uridine modifications by Elongator, Urmylation and Trm9--Trm112 pathway components are boxed in *blue*, *yellow* and *red*, respectively. Newly identified genes are shown on a *green* background encircled by a *continuous line*; a previously known gene involved in this pathway (*URM1*) that was also identified in our screen is shown on a *green* background encircled by a *dotted line*; two components encoded by genes not present in the deletion mutant collection are shown in *gray*. (**B**) Mitochondrial protein synthesis analysis carried out at 30 and 37°C in the wild type strain and in the *elp3Δ* and *ncs6Δ* mutant strains. A bar-plot representation of the data obtained at 37°C from three independent experiments for the indicated deletion mutant strains and mitochondrial polypeptides (polypeptide levels in the mutant compared to the wild type strain ± SD) is shown below the gel autoradiography; significant differences (\*\*\**P*-value ≤ 0.001) between mutant and wild type polypeptide levels are indicated.](gkv765fig2){#F2}

###### GO Biological process analysis of new genes involved in mitochondrial biogenesis under stress conditions

  GO term                                                                                    *P*-value
  ------------------------------------------------------------------------------------------ -----------
  tRNA wobble uridine modification \[GO:0002098\]                                            2.1E−10
  Regulation of transcription from RNA polymerase II promoter \[GO:0006357\]                 1.2E−07
  Protein urmylation \[GO:0032447\]                                                          3.8E−06
  Ubiquitin-dependent protein catabolic process via the MVB sorting pathway \[GO:0043162\]   5.3E−06
  Late endosome to vacuole transport \[GO:0045324\]                                          2.6E−05
  Protein processing \[GO:0016485\]                                                          5.1E−05
  Protein targeting to vacuole \[GO:0006623\]                                                9.7E−05

Other biological processes significantly represented among the newly identified respiration-defective mutants are 'regulation of transcription from RNA polymerase II promoter' (*P-*value = 1.2E−07), 'ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway' (*P-*value = 5.3E−06), 'protein processing' (*P-*value = 5.1E−05) and 'protein targeting to vacuole' (*P-*value = 9.7E−05) (Table [2](#tbl2){ref-type="table"}; see 'Discussion').

Defective tRNA^Lys^~UUU~ wobble uridine modification indirectly affects mitochondrion integrity under heat stress conditions {#SEC3-4}
----------------------------------------------------------------------------------------------------------------------------

Among the multiple relevant pathways identified in our screen, we chose to focus on tRNA wobble uridine modification, the most GO-supported and functionally homogenous class of mutants. We initially examined mitochondrial protein synthesis (MPS) in three mutants, *elp3Δ*, *trm9Δ* and *ncs6Δ*, representative of the three main steps of tRNA U~34~ modification ([@B54]--[@B56]) (Figure [2B](#F2){ref-type="fig"}). *Elp3Δ* and *ncs6Δ* were scored as MS mutants based on their growth-phenotype on non-fermentable carbon sources at 37°C, yet displayed fairly strong respiratory chain and oxygen consumption defects and were both classified as class B mutants. Under the same conditions, *trm9Δ* behaved as an LS mutant with only a slightly defective cytochrome spectrum and respiratory rate (class D mutant; Supplementary Table S5).

Mitochondrial protein synthesis was analyzed by pulse-labelling experiments carried out at both 30 and 37°C in the presence of ^35^S-methionine and cycloheximide, an inhibitor of cytosolic translation. Following ^35^S-methionine incorporation into newly synthesized mitochondrial proteins, labeled cell extracts were gel-fractionated and radioactivity levels associated to individual polypeptide bands in the mutants and in the wild type strain were determined. No significant differences between mutants and wild type were observed at 30°C (Figure [2B](#F2){ref-type="fig"}). In contrast, a fairly strong reduction in ^35^S-methionine incorporation was apparent in the *ncs6Δ* and *elp3Δ* strains at 37°C. Under the same conditions, ^35^S-methionine incorporation in the *trm9Δ* mutant was not significantly different from that of the wild type strain (data not shown).

The mitochondrial translation defect observed in the *ncs6Δ* and *elp3Δ* strains at 37°C is not accounted for by mtDNA instability, since the frequency of conversion to *rho^0^*/*rho^−^* cells in the mutant strains did not differ from wild type (data not shown).

U~34~ modification by Elp3, Trm9 and Ncs6 is found exclusively on lysine (UUU), glutamine (UUG) and glutamic acid (UUC) tRNAs ([@B43],[@B53]), although other ELP pathway-dependent modifications (namely, mcm^5^U~34~, ncm^5^U~34~ and ncm^5^U~34~m) are present on eight additional tRNAs bearing an UXX anticodon ([@B57]) (Figure [2A](#F2){ref-type="fig"}). Mcm^5^s^2^ uridine modification has been shown to be dispensable for general translation, but required to positively modulate translation of AAA, CAA, and GAA codon-rich mRNAs under stress conditions through an increased occupancy of the ribosome A-site by the corresponding aminoacyl tRNAs ([@B43],[@B58]). Importantly, the mcm^5^s^2^-modified glutamine (UUG) tRNA is one of three tRNAs \[the others are lysine (CUU) and glutamine (CUG)\] that are imported into mitochondria in yeast ([@B12],[@B13]). Therefore, a defective ELP-Urm pathway might affect mitochondrial gene expression, specifically mitochondrial translation, by interfering with mcm^5^s^2^-modification of the mitochondrially imported glutamine (UUG) tRNA. Alternatively, ELP-Urm mutations might impair the cytosolic synthesis of proteins that are required for mitochondrial gene expression and function under heat stress conditions. These proteins should be encoded by mRNAs with a high content of codons (AAA, CAA, GAA) read by one or more of the U~34~-modified tRNAs; this contrasts, however, with the generally low content of such codons in the mRNAs for the mitochondrial proteins (shown in Figure [2B](#F2){ref-type="fig"}) whose synthesis was found to be impaired in the *elp3Δ* and *ncs6Δ* mutants under heat-stress conditions (data not shown). We thus reasoned that if the respiratory defect displayed by these mutants is due to a codon-specific cytoplasmic translation impairment, it could be alleviated by overexpression of the corresponding specific tRNAs, as previously observed in other cases of crippled tRNA modification in yeast ([@B58]--[@B60]). Accordingly, we overexpressed a series of candidate and control tRNA genes into the *elp3Δ* mutant strain and tested the ability of the resulting transformants to grow on ethanol at 37°C. In a first set of experiments (Figure [3A](#F3){ref-type="fig"}--[C](#F3){ref-type="fig"}), we tested the rescue capacity of two tRNAs modified by the ELP-Urm pathway (tRNA^Lys^~UUU~ and tRNA^Gln^~UUG~), the latter of which has also been shown to be imported into mitochondria ([@B12]); three tRNAs that are only targeted by ELP-dependent modification (tRNA^Thr^~UGU~, tRNA^Gly^~UCC~ and tRNA^Arg^~UCU~); and the other two mitochondrially imported tRNAs that do not to undergo U~34~ modification (tRNA^Gln^~CUG~, tRNA^Lys^~CUU~). tRNA^Lys^~CUU~, in particular, served as a control for a tRNA that, at variance with the non-mitochondrially imported tRNA^Lys^~UUU~, is internalized into mitochondria in an unmodified form at 37°C ([@B13]). As shown in Figure [3A](#F3){ref-type="fig"}-[C](#F3){ref-type="fig"}, only tRNA^Lys^~UUU~ rescued the defective respiratory phenotype of the *elp3Δ* mutant at 37°C (at levels only slightly lower than those of a *ELP3* control transformant) and also restored cytochrome spectra and oxygen consumption rates, while no effect was observed with the mitochondrially imported tRNA^Gln^~UUG~. In a second set of experiments (separately carried out with a different plasmid under different selection conditions), we tested the respiratory growth capacity of the *elp3Δ* mutant strain transformed with tRNA^Glu^~UUC~, two of the previously tested tRNAs (tRNA^Gln^~UUG~ and the rescue-proficient tRNA^Lys^~UUU~), plus a combination of the three tRNAs all carried by the same vector. As further shown in Figure [3](#F3){ref-type="fig"} (panels D--F), despite a slightly lower quantitative effect compared to the results in Figure [3A](#F3){ref-type="fig"}-[C](#F3){ref-type="fig"}, also in this case tRNA^Lys^~UUU~ proved to be the only one, among the three tested tRNAs, capable of rescuing the respiratory growth defect, cytochrome spectrum and oxygen consumption rate of the *elp3Δ* mutant strain at 37°C. Curiously, while neither tRNA^Gln^~UUG~ nor tRNA^Glu^~UUC~ displayed any rescue capacity individually, a higher recovery of mitochondrial function (especially oxygen consumption rate) was observed in the case of the triple transformant. It thus appears that similar to what was previously reported for other Elongator related phenotypes ([@B58],[@B61]), tRNA^Lys^~UUU~ is the only tRNA capable of rescuing the mitochondrial abnormalities caused by *ELP3* disruption. Given the exclusively cytoplasmic localization of tRNA^Lys^~UUU~ ([@B13]) and the lack of effect of the mitochondrion-imported tRNA^Lys^~CUU~, the unique ability of this tRNA to alleviate the respiratory growth defect of the *elp3Δ* mutant suggests that wobble uridine modification of tRNA^Lys^~UUU~ is required to attain adequate levels of translation of cytosolic proteins that are necessary for mitochondrial gene expression and function.

![tRNA^Lys^~UUU~ overexpression rescues the respiratory growth defect of the *elp3****Δ*** mutant. (**A**) OXPHOS phenotypes of the indicated *elp3Δ*-tRNA gene (YEp352 vector with *URA3* as auxotrophic marker) transformants grown at 37°C on glucose (SCD) or ethanol (SCE) synthetic medium (the latter supplemented with a non-repressive 0.005% glucose concentration). *Elp3Δ* cells transformed with the empty YEp352 vector and the same vector carrying the wild type *ELP3* gene were used as negative and positive controls, respectively; two different tRNA^Lys^~UUU~ genes \[*tK(UUU)L*, \#1; *tK(UUU)D*, \#2\] were assayed. Cytochrome spectra and oxygen consumption rates of the indicated *elp3Δ*-tRNA gene transformants are shown in panels (**B**) and (**C**), respectively. (**D**) OXPHOS phenotype assays as in (**A**) testing one further tRNA (tRNA^Glu^~UUC~) plus a triple combination of tRNA^Lys^~UUU~, tRNA^Gln^~UUG~ and tRNA^Glu^~UUC~ (*tKQE*), in addition to an independent replicate of the single tRNA^Lys^~UUU~ and tRNA^Gln^~UUG~, all carried by the pRS425 vector (*LEU2* auxotrophic marker). Cytochrome spectra and oxygen consumption rates of the same set of transformants are shown in panels (**E**) and (**F**). Error bars represent the mean ± SD; significant differences (\*\**P*-value ≤ 0.01) are indicated.](gkv765fig3){#F3}

Increased dosage of two AAA codon-rich mRNAs encoded by genes that cause respiratory deficiency when deleted rescues the respiration-defective phenotype of the *elp3Δ* mutant at 37°C {#SEC3-5}
--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

tRNA^Lys^~mcm~^5^~s~^2^~UUU~ has been shown to preferentially, if not exclusively, read the AAA codon ([@B43],[@B60],[@B62]). Accordingly, we hypothesized that translation of AAA codon-rich mRNAs encoded by genes that cause respiratory deficiency when deleted might be particularly sensitive to the defective wobble uridine modification taking place in *elp3Δ* and thus causally related to the OXPHOS phenotype of this mutant. Accordingly, the associated respiratory deficiency should be suppressed, at least in part, by overexpression of such genes -a predicted outcome that has been experimentally verified in other cases of altered tRNA modification (e.g. ([@B63])). To test this hypothesis, we ranked the 489 genes whose deletion causes respiratory deficiency in our screen according to their AAA-codon usage bias (paying special attention to tandemly repeated AAA codons) and the 10 top-scoring genes (see Supplementary Table S3) were transformed into the *elp3Δ* mutant and assayed for their ability to rescue the respiratory phenotype of this strain. As shown in Figure [4](#F4){ref-type="fig"}, overexpression of two genes, *BCK1* and *HFM1*, apparently unrelated to mitochondrial function restored respiratory capacity (panel A) as well as cytochrome spectrum and oxygen consumption rate (panels B and C) of the *elp3Δ* mutant under heat stress conditions. Additional data reported in Figure [5](#F5){ref-type="fig"} show that this rescue effect is comparable to that produced by the wild type version of *ELP3* (panel A); that a similar, albeit reduced effect (in the case of *BCK1*) is elicited in the functionally related *ncs6Δ* mutant (panel B); while no amelioration of respiratory growth is observed under identical conditions in two mutants (*spt7Δ* and *med2Δ*, both displaying an MS respiratory phenotype as *elp3Δ* and *ncs6Δ*) functionally unrelated to wobble uridine tRNA modification (panel C). *BCK1* codes for a mitogen-activated protein kinase kinase (MAPKK) kinase acting in the protein kinase C (PKC) signalling pathway ([@B64]), while *HFM1* codes for a DNA helicase involved in modulation of genome integrity ([@B65]) (see 'Discussion').

![Increased dosage of the AAA codon-rich genes *BCK1* and *HFM1* rescues respiratory deficiency in the *elp3Δ* mutant under heat stress conditions. (**A**) Growth performance of the *elp3Δ* strain transformed with a multicopy expression vector (pGB1805; *URA3* auxotrophic marker, *GAL1* promoter) harbouring the indicated AAA codon-rich genes. Transformants were cultured on fermentative (SCD, *left panel*) or oxidative (SCE supplemented with 0.005% glucose) medium, in the absence (*middle panel*) or the presence (*right panel*) of 2% galactose at 37°C. The ρ° and *elp3Δ* strains served as negative controls; the *HFM1* and the *BCK1* transformants were assayed in duplicate. Cytochrome spectra and oxygen consumption rates of the *elp3Δ-BCK1* and *elp3Δ-HFM1* transformants are shown in panels (**B**) and (**C**). Significant differences (\*\*\**P*-value ≤ 0.001) between the respiratory capacity of *elp3Δ* and the *BCK1*/*HFM1* transformants are indicated.](gkv765fig4){#F4}

![Mutant strain specificity of *BCK1-* and *HFM1-*mediated suppression. (**A**) Respiratory growth performance (37°C) of the *elp3Δ* strain overexpressing *BCK1*- and *HFM1* compared with that of the same strain transformed with a *ELP3* overexpressing plasmid (positive control); *elp3Δ* served as a negative control for these experiments. Cells cultured at 37°C on glucose (SCD) or ethanol (SCE) plus galactose medium are shown in the *left* and the *right panels*, respectively. (**B**) Respiratory growth serial dilution assays as in (**A**) conducted on the *ncs6Δ* mutant. (**C**) Respiratory growth assays conducted with *BCK1*- and *HFM1* in two mutant strains (*spt7Δ* and *med2Δ*) functionally unrelated to wobble uridine modification.](gkv765fig5){#F5}

DISCUSSION {#SEC4}
==========

Defining the mitochondrial proteome and its regulome under standard and stress conditions is a prerequisite for fully understanding mitochondrial physiology in health and disease. Given the strong evolutionary conservation of essential biochemical pathways from yeast to mammals, the characterization of the mitochondrial regulatory network in humans can benefit from comprehensive high-throughput studies in *S. cerevisiae*. Here, we combined the negative effect of heat stress on respiratory capacity with the discovery potential of a genome-wide phenotypic screening in yeast to expand the repertoire of genes affecting mitochondrial function. This allowed the identification of 105 new genes and novel pathways, most notably wobble uridine tRNA modification, which cause respiratory deficiency when disrupted. A total of 124 mutants (including all the newly identified genes and a subset of poorly characterized genes with a purported role in mitochondrial biogenesis) were functionally tested for mitochondrial respiratory chain (MRC) integrity and oxygen consumption capacity. Given the good correlation between respiratory growth, oxygen consumption rate and cytochrome spectra, the OXPHOS-negative phenotype of at least 86% of the mutants appears to be causally related to MRC impairment. We cannot exclude, however, the possibility that a mild respiratory impairment might underlie the defective phenotypes of at least a subset of the class D mutants (Supplementary Table S5). A role distinct from cellular respiration must be postulated, instead, for the six class D mutants that displayed a HS OXPHOS phenotype (*vps8Δ, rpl23BΔ, erg4Δ, pho86Δ, rav1Δ, srn2Δ*; Supplementary Tables S5 and S6).

Most genes whose deletion causes respiratory deficiency at 37°C code for non-mitochondrial proteins that may indirectly impinge on mitochondrion structure or function. These include the CAP-binding complex proteins Cbc2 and Sto1, various transcriptional regulators (e.g. Ume6, Mss11, Gcr2, Smi1, Rim101, Swi6) as well as chromatin remodeling components (e.g. Spt8, Eaf7, Rtt109, Rsc2), for some of which indirect evidence pointing to a role in mitochondrial biogenesis has been reported before ([@B26],[@B66]) (Supplementary Table S5). Additional mutants include deletants in four genes (*rim20Δ, rim21Δ*, *rim8Δ* and *dfg16Δ*) involved in the proteolytic activation of the transcriptional repressor Rim101, which regulates cell wall assembly as well as metal ion and alkaline pH tolerance (([@B39],[@B67],[@B68]) and references therein). Potentially related hits comprise 11 components of the Endosomal Sorting Complex Required for Transport (ESCRT) I, II and III complexes (Supplementary Table S1), some of which (e.g. Spt22, Snf7 and Vps20) interact with Rim20 and are required for proteolytic activation of Rim101 ([@B69]). Of note, a causal relationship between vacuolar pH, endosomal trafficking and mtDNA stability has been recently reported ([@B70]).

Further genes whose deletion causes respiratory deficiency even at 30°C code for specific components of the transcription/chromatin remodeling (e.g. Med2, Spt8, Ctf4) and cytosolic translation (e.g., Rpl39, Rps27b) machineries. These include *PEX5*, a gene coding for a membrane receptor required for peroxisomal matrix protein import whose deletion causes a severe respiratory decline as well as specific defects in respiratory complex assembly (OXPHOS, class A mutant; Supplementary Table S5). Interestingly, mitochondrial respiratory alterations have been reported in a *PEX5* knockout mouse model of Zellweger Syndrome with defective peroxisomal biogenesis ([@B71]).

The most peculiar and comprehensive class of genes for which we discovered a previously unknown role in mitochondrial biogenesis at 37°C codes for proteins involved in 5-methoxycarbonylmethyl-2-thiouridine formation at the U~34~ position of some cytoplasmic tRNAs, a modification required for efficient mRNA decoding under stress conditions ([@B43],[@B58]). These include ELP and Urm pathway components and the tRNA methyltransferase Trm9. Interestingly, a similarly comprehensive repertoire of wobble uridine tRNA modification components has been retrieved from a screening for genes whose mutation abolishes sensitivity to zymocin, a toxin that cleaves tRNAs only when they bear the U~34~-mcm^5^s^2^modification ([@B53]). The first step of this modification, catalysed by the ELP complex, is U~34~-cm^5^ formation on 11 UXX tRNAs, that is followed by a second, Trm9-mediated methylation (U~34~-mcm^5^) of five tRNAs, three of which (tRNA^Gln^~UUG~, tRNA^Lys^~UUU~ and tRNA^Glu^~UUC~) are thiolated by Ncs6-Ncs2 to produce mcm^5^s^2^U~34~. Deletion of genes (*ELP3* and *NCS6*) critically involved in the first and third step of wobble uridine modification strongly impairs MPS, whereas no appreciable MPS defect was observed in the *trm9Δ* mutant (Figure [2B](#F2){ref-type="fig"}). This is in agreement with previous results indicating a relatively minor and growth condition-dependent effect of Trm9-catalyzed methylation on the decoding properties of at least some of its tRNA targets ([@B57]). Yeast mitochondria encode an apparently complete set of tRNAs, yet three nuclear-encoded tRNAs (tRNA^Lys^~CUU~, tRNA^Gln^~CUG~ and tRNA^Gln^~UUG~) are known to be imported into mitochondria ([@B12],[@B13],[@B72]). In particular, it has been shown that tRNA^Lys^~CUU~ import is dispensable for oxidative growth at 30°C, but becomes essential at 37°C ([@B13]). This is likely explained by the fact that wobble uridine thiolation of the mitochondrially encoded tRNA^Lys^~UUU~ is impaired at 37°C, thus preventing efficient decoding of the lysine AAG codon under temperature stress conditions ([@B13]). It is less clear, instead, the need for mitochondrial import of the nuclear-encoded tRNA^Gln^~UUG~, for which a tRNA bearing the same anticodon is encoded by the mitochondrial genome. The fact that tRNA^Gln^~UUG~, one of the tRNAs modified by the ELP-Urm pathway ([@B57]), is imported into mitochondria led us to hypothesize that the depressed MPS observed in the *elp3Δ* and *ncs6Δ* mutants might result from a hypomodification of this particular tRNA at 37°C. Such an effect, however, seems incompatible with the lack of any significant cognate codon (CAA) enrichment in the mRNAs coding for the mitochondrial polypeptides monitored by the MPS assay (data not shown and Figure [2B](#F2){ref-type="fig"}). Moreover, the fact that overexpression of tRNA^Gln^~UUG~ alone failed to rescue respiratory deficiency at 37°C further argues against the hypothesis that a defective ELP-Urm pathway might negatively affect MPS by interfering with wobble uridine modification of this particular tRNA. Instead, our data indicate an indirect effect of tRNA hypomodification on mitochondrial biogenesis caused by impaired translation of a specific subset of cytoplasmic proteins required for optimal mitochondrial function. This is strongly supported by the respiratory growth rescue ability exhibited by plasmid vectors overexpressing only tRNA^Lys^~UUU~, a tRNA with an exclusively cytoplasmic localization ([@B13]). It is interesting to note, in this regard, that the peroxide hypersensitivity phenotype displayed by fission yeast *elp3* deletants is similarly rescued by tRNA^Lys^~UUU~ overexpression ([@B58]). So, despite the as yet unexplained increase in the suppression of defective respiration (especially oxygen consumption rate) observed with the triple construct bearing two other tRNAs (tRNA^Gln^~UUG~ and tRNA^Glu^~UUC~) in addition to tRNA^Lys^~UUU~, it appears that the latter tRNA is responsible for respiratory growth rescue and that efficient translation of mRNAs with a high content of AAA codons is critically required to optimize mitochondrial function. Further to this point, the yeast genome displays a strong imbalance in gene copy number for the two cytoplasmic tRNA^Lys^, with 14 copies of tRNA^Lys^~CUU~ but only seven copies of the tRNA^Lys^~UUU~ gene ([@B73]).

In keeping with the above hypothesis, multicopy suppression-based testing of 10 nuclear genes with a high AAA codon content (see Supplementary Table S3) and causing a respiratory defective phenotype when deleted, identified two genes (*BCK1* and *HFM1*) that specifically rescue the respiratory growth defect of the *elp3Δ* and *ncs6Δ* mutants, but not of functionally unrelated mutants, at 37°C. Bck1 is the MAPKK kinase component of a PKC1 signalling pathway involved in the control of cell integrity. Deletion of this gene caused a HS phenotype in our screen but has never been directly related to a respiratory growth defect. It is interesting to note, however, that Slt2, the MAPK component of the PKC1 signalling pathway in which Bck1 is involved and that was also identified as a respiratory deficient mutant (Supplementary Table S1), has recently been shown to impair yeast growth on glycerol when mutated ([@B74]). Although the essential nature of *PKC1* prevented its examination in the present screen, the above data suggest a generalized involvement of the PKC1-Bck1-Slt2 pathway in the maintenance of mitochondrial function. Other potential links between Bck1 and mitochondrial function have been suggested by two previous genome-wide studies, which revealed a protective role of this kinase against reactive oxygen species in yeast cells treated with farnesol ([@B64]) as well as its involvement in mitophagy ([@B75]), the process responsible for the removal of unfitted mitochondria. Also notable are the negative genetic synthetic interactions of *BCK1* deletion with *ELP3, ELP4, ELP6* and *NCS6* deletions ([@B76]). Our observation may thus be explained by an as yet uncharacterized, but apparently critical involvement of Bck1 in mitochondrial biogenesis/turnover and function.

Hfm1 (also known as Mer3) is a meiosis-specific DNA helicase ([@B65]) for which no specific link to mitochondria has been reported so far. The *hfm1* disruptant was classified as MS at 37°C, but also exhibited a clear, although less intense, respiratory growth phenotype at 30°C, consistently with another OXPHOS screen conducted at this temperature ([@B29]). Evidence for a non-exclusive, meiosis-related role also emerged from two other genome-wide studies, in which *HFM1* was retrieved as a gene involved in the utilization of dipeptides, a major nitrogen source for microbial as well as mammalian cells ([@B77]), with also a role in the control of chronological life span ([@B78]). Interestingly, dipeptide production/utilization is regulated by the ubiquitin proteasome system ([@B79]), another well covered biological process that we found to be required for oxidative growth under heat stress (Table [2](#tbl2){ref-type="table"}). What is perhaps even more relevant is that various nuclear yeast and mammalian DNA helicases (e.g., Pif1) are involved in the maintenance of mtDNA integrity ([@B80]).

The ELP complex was originally identified as an RNA polymerase II-associated transcription elongation factor, and subsequently shown to be involved also in wobble uridine tRNA modification (([@B58],[@B59]) and references therein). The latter function appears to be central to ELP action and may indirectly explain other cellular defects associated to ELP mutations in various organisms through an attenuated and aberrant translation of proteins playing critical roles in specific cellular processes or stress responses. These include temperature, chemical and starvation stress sensitivity, transcriptional/chromatin remodeling, telomeric silencing, DNA damage response and cell division defects in yeast (([@B60],[@B81]) and references therein), neurological alterations in *C. elegans* and in humans (e.g. familial dysautonomia, amyotrophic lateral sclerosis and Rolandic epilepsy ([@B82]--[@B85])) as well as altered neuron migration caused by defective α-tubulin acetylation ([@B86]) and impaired zygotic paternal genome demethylation ([@B87]). Our results extend the range of ELP roles to mitochondrial function and demonstrate an equally important involvement in this process of the Urm complex responsible for wobble uridine tRNA thiolation ([@B49]). All the components of the yeast wobble uridine tRNA modification machinery as well as the AAA codon-rich suppressor genes *BCK1* and *HFM1* are orthologous to human genes. Beyond these pathways, approximately 70% of the new genes revealed by our screen are orthologous to human genes. Also worth of note is the known causal association between mutations interfering with wobble base modification of some mitochondrial tRNA genes and human neurodegenerative mitochondriopathies such as MERF (Myoclonic Epilepsy with Ragged Red Fibers) and MELAS (Myopathy, Encephalopathy, Lactic Acidosis, and Stroke-like episodes) ([@B88]). This opens the possibility that wobble base modification impairing mutations targeting tRNA^Lys^~UUU~, including ELP/Urm complex mutations, may be similarly involved in as yet poorly understood human mitochondrial pathologies. Therefore, future studies mining the findings presented in this work are expected to facilitate a better understanding of the human mitochondrial regulome in health and mitochondrial disease as well as in diseases of broad social impact such as age-related neurodegenerative disorders.
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